Stockscreener 앱 받기
15.88
0.19%
0.03
시간 외 거래:
15.88
Personalis Inc 주식(PSNL)의 최신 뉴스
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law - Business Wire
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law - FinancialContent
No merger-related layoffs are anticipated by Personalis (PSNL) as Tempus takeover awaits closing. - Stock Titan
Personalis (Nasdaq:PSNL)Stock Analysis - Simply Wall Street
BTIG downgrades Personalis stock rating to neutral on acquisition outlook - Investing.com
PSNL SC 13E3/A & SEC FilingsYahoo Finance - Yahoo! Finance Canada
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com
Personalis CFO and COO Aaron Tachibana sells $47,540 in stock - Investing.com
Personalis president & CMO Chen sells $64,847 of PSNL stock - Investing.com
Personalis CEO Christopher Hall sells $120,984 in company stock - Investing.com
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com Australia
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com Canada
Personalis CEO Christopher Hall sells $120,984 in company stock By Investing.com - Investing.com Nigeria
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL) - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL) - Supply Chain Digital Magazine
Personalis President and CMO Richard Chen Executes Stock Sale for Tax Withholding - Kalkine Media
Personalis CLO Stephen Michael Moore Sells 2,068 Shares for RSU Tax Withholding - Kalkine Media
Tempus move on Personalis (NASDAQ: PSNL) hinges on cancer tests and data from 50 million patients - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - tradingview.com
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. - WSJ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Tempus AI shares rise 5.1% to $70 on Moderna cancer trial validation - scanx.trade
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next. - webull.com
Personalis Inc Stock Historical Valuations | FRA:04X - GuruFocus
Personalis Inc Stock Operating Data - GuruFocus
PSNL SC 13E3 & SEC FilingsYahoo Finance - Yahoo! Finance Canada
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated? - Yahoo Finance
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next. - Barchart.com
Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win - webull.com
Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win - simplywall.st
Personalis falls amid a downgrade as a competitive bid appears unlikely - Seeking Alpha
Tempus AI soars 40% in a week, adding $3.7 billion—over double the Personalis acquisition amount - TechStock²
Tempus AI (TEM) Is Up 39.5% After mRNA Melanoma Trial Win And Personalis DealWhat's Changed - Yahoo Finance
A Look at Personalis Inc (PSNL) After 8.8% Gain -- GF Value $2.4 - GuruFocus
Tempus AI Shares Jump $3 Billion After Moderna Victory Boosts Value of $1.5 Billion Personalis Stake - TechStock²
AMERIPRISE FINANCIAL INC Trims Personalis Inc (PSNL) Stake -- Shares Trade 590% Above GF Value - GuruFocus
Why Tempus AI (TEM) Is Up 22.8% After Buying the Platform Behind a Key mRNA Cancer Win - simplywall.st
Deep Track Capital, LP Trims Personalis Inc (PSNL) Stake -- Shar - GuruFocus
Personalis secures new Million Veteran Program task order - TipRanks
Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP - TradingView
Personalis wins up to $18.3M VA MVP task order, cumulative VA awards reach $243.3M - TradingView
Personalis (NASDAQ: PSNL) wins Million Veteran Program task order—how big is it? - Stock Titan
Tempus soars on coattails of Moderna/Merck cancer vaccine - Crain's Chicago Business
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - TradingView
Personalis stock reaches 52-week high at 16.42 USD - Investing.com
Personalis stock reaches 52-week high at 16.42 USD By Investing.com - Investing.com Canada
Tempus AI Just Had Their Entire Strategy Validated By Moderna’s Vaccine Advance (TEM) - Seeking Alpha
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - Stocktwits
9.10%
0.39%
자본화:
|
볼륨(24시간):